NCT01302275

Oxcarbazepine for the Treatment of Chronic Peripheral Neuropathic Pain

Oxcarbazepine for the Treatment of Chronic Peripheral Neuropathic Pain: Predictors of Response - a Randomised, Double-blind, Placebo-controlled Clinical Trial

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 117 (actual)
• Sponsor: Søren H. Sindrup · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this trial is to determine if the effect of oxcarbazepine on chronic peripheral nerve pain depends on the supposed mechanism of the pain, ie. if oxcarbazepine mainly relieve pain in patients with irritable nerves.

Conditions

• Polyneuropathy
• Peripheral Nerve Injury
• Postherpetic Neuralgia

Interventions

Type	Name	Description
DRUG	Oxcarbazepine	Oxcarbazepine capsules 300 mg is gradually increased from 300 mg/day to 2400 mg/day Placebo capsules increase from 1/day to 8/day

Timeline

• Start date: 2011-02-01
• Primary completion: 2013-05-01
• Completion: 2013-05-01
• First posted: 2011-02-24
• Last updated: 2014-05-05

Locations

2 sites across 1 country: Denmark